Luminai
PrivateLast Round
Series B
Apr 9, 2026
Est. Valuation
$152M
Total Funding Raised
$57.93M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Luminai operates in Enterprise Software and is based in San Francisco, California. Its latest recorded funding round was a Series B round in April 2026.
Luminai is a healthcare software company that provides an AI-native enterprise automation platform designed to automate complex administrative and operational workflows for health systems.
Sector
Enterprise Software
Verticals
Workflow Automation, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminai Comparables
Compare Luminai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sola | 83% | |
| SS&C Technologies Holdings Inc | 75% | |
| Microsoft | 72% |
For institutional investors. Book with your work email.
Luminai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 9, 2026 | ||||
| Series A | Jun 9, 2022 | ||||
| Seed | Oct 7, 2020 | ||||
| Accelerator | Aug 25, 2020 | ||||
| Accelerator | May 1, 2020 | ||||
Pre Seed | Mar 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Luminai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Define Ventures | Series B |
| Wayfinder Ventures | Seed |
| Peak XV Partners | Series B |
| Weekend Fund | Series A, Seed |
| Craft Ventures | Series B, Series A |
| Unshackled Ventures | Series B, Series A, Seed, Pre Seed |
| Scribble Ventures | Series B, Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Grew 19% QoQ, from 54 to 64 employees.
- Jul 16, 2026
Cleveland Clinic disclosed as a new customer.
For institutional investors. Book with your work email.
Luminai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Luminai's valuation, stock price, and market status.
Is Luminai a public or private company?
Luminai is a private company.
What is the current stock price of Luminai?
Luminai is a private company, so its shares have no public market price. Caplight tracks Luminai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Luminai worth (valuation)?
Luminai's valuation is estimated at $152.0M based on funding round data.
Can I buy Luminai stock?
Luminai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Luminai's last funding round?
Luminai's most recent funding round was Series B on April 9, 2026.
Who are the main investors in Luminai?
Key investors in Luminai include Peak XV Partners, Unshackled Ventures, General Catalyst, Y Combinator, Moxxie Ventures.
Will Luminai IPO soon?
No public IPO plans have been announced for Luminai.
How can I track Luminai secondary market activity?
Caplight tracks bids, offers, and trades in Luminai's shares on secondary markets.